Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.
Market Analysis and Insights: Global Ciclopirox Olamine Market
The global Ciclopirox Olamine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ciclopirox Olamine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ciclopirox Olamine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ciclopirox Olamine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ciclopirox Olamine market.
Ciclopirox Olamine Breakdown Data by Type
Cream Preparation
Temperture
Vaginal Suppository
Ciclopirox Olamine Breakdown Data by Application
Ringworm Of The Body
Athlete'S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other
Based on regional and country-level analysis, the Ciclopirox Olamine market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Ciclopirox Olamine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc's Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Market Analysis and Insights: Global Ciclopirox Olamine Market
The global Ciclopirox Olamine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ciclopirox Olamine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ciclopirox Olamine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ciclopirox Olamine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ciclopirox Olamine market.
Ciclopirox Olamine Breakdown Data by Type
Cream Preparation
Temperture
Vaginal Suppository
Ciclopirox Olamine Breakdown Data by Application
Ringworm Of The Body
Athlete'S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other
Based on regional and country-level analysis, the Ciclopirox Olamine market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Ciclopirox Olamine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc's Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ciclopirox Olamine Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Cream Preparation
1.2.3 Temperture
1.2.4 Vaginal Suppository
1.3 Market by Application
1.3.1 Global Ciclopirox Olamine Market Share by Application: 2020 VS 2026
1.3.2 Ringworm Of The Body
1.3.3 Athlete'S Foot
1.3.4 Tinea
1.3.5 Tinea Versicolor
1.3.6 Candida Albicans
1.3.7 Gynecological Anti-Infection Preparation
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ciclopirox Olamine Market Perspective (2015-2026)
2.2 Global Ciclopirox Olamine Growth Trends by Regions
2.2.1 Ciclopirox Olamine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ciclopirox Olamine Historic Market Share by Regions (2015-2020)
2.2.3 Ciclopirox Olamine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ciclopirox Olamine Players by Market Size
3.1.1 Global Top Ciclopirox Olamine Players by Revenue (2015-2020)
3.1.2 Global Ciclopirox Olamine Revenue Market Share by Players (2015-2020)
3.2 Global Ciclopirox Olamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ciclopirox Olamine Revenue
3.4 Global Ciclopirox Olamine Market Concentration Ratio
3.4.1 Global Ciclopirox Olamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ciclopirox Olamine Revenue in 2019
3.5 Key Players Ciclopirox Olamine Area Served
3.6 Key Players Ciclopirox Olamine Product Solution and Service
3.7 Date of Enter into Ciclopirox Olamine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ciclopirox Olamine Breakdown Data by Type (2015-2026)
4.1 Global Ciclopirox Olamine Historic Market Size by Type (2015-2020)
4.2 Global Ciclopirox Olamine Forecasted Market Size by Type (2021-2026)
5 Ciclopirox Olamine Breakdown Data by Application (2015-2026)
5.1 Global Ciclopirox Olamine Historic Market Size by Application (2015-2020)
5.2 Global Ciclopirox Olamine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ciclopirox Olamine Market Size (2015-2026)
6.2 North America Ciclopirox Olamine Market Size by Type (2015-2020)
6.3 North America Ciclopirox Olamine Market Size by Application (2015-2020)
6.4 North America Ciclopirox Olamine Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Ciclopirox Olamine Market Size (2015-2026)
7.2 Europe Ciclopirox Olamine Market Size by Type (2015-2020)
7.3 Europe Ciclopirox Olamine Market Size by Application (2015-2020)
7.4 Europe Ciclopirox Olamine Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Ciclopirox Olamine Market Size (2015-2026)
8.2 China Ciclopirox Olamine Market Size by Type (2015-2020)
8.3 China Ciclopirox Olamine Market Size by Application (2015-2020)
8.4 China Ciclopirox Olamine Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Ciclopirox Olamine Market Size (2015-2026)
9.2 Japan Ciclopirox Olamine Market Size by Type (2015-2020)
9.3 Japan Ciclopirox Olamine Market Size by Application (2015-2020)
9.4 Japan Ciclopirox Olamine Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Ciclopirox Olamine Market Size (2015-2026)
10.2 Southeast Asia Ciclopirox Olamine Market Size by Type (2015-2020)
10.3 Southeast Asia Ciclopirox Olamine Market Size by Application (2015-2020)
10.4 Southeast Asia Ciclopirox Olamine Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ciclopirox Olamine Introduction
11.1.4 Bayer Revenue in Ciclopirox Olamine Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 Apotex Corporation
11.2.1 Apotex Corporation Company Details
11.2.2 Apotex Corporation Business Overview
11.2.3 Apotex Corporation Ciclopirox Olamine Introduction
11.2.4 Apotex Corporation Revenue in Ciclopirox Olamine Business (2015-2020)
11.2.5 Apotex Corporation Recent Development
11.3 Fougera (Sandoz)
11.3.1 Fougera (Sandoz) Company Details
11.3.2 Fougera (Sandoz) Business Overview
11.3.3 Fougera (Sandoz) Ciclopirox Olamine Introduction
11.3.4 Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2015-2020)
11.3.5 Fougera (Sandoz) Recent Development
11.4 Medimetriks Pharmaceuticals
11.4.1 Medimetriks Pharmaceuticals Company Details
11.4.2 Medimetriks Pharmaceuticals Business Overview
11.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Introduction
11.4.4 Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.4.5 Medimetriks Pharmaceuticals Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Details
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Ciclopirox Olamine Introduction
11.5.4 Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Preferred Pharmaceuticals
11.6.1 Preferred Pharmaceuticals Company Details
11.6.2 Preferred Pharmaceuticals Business Overview
11.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Introduction
11.6.4 Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.6.5 Preferred Pharmaceuticals Recent Development
11.7 Ingenus Pharmaceuticals
11.7.1 Ingenus Pharmaceuticals Company Details
11.7.2 Ingenus Pharmaceuticals Business Overview
11.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Introduction
11.7.4 Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.7.5 Ingenus Pharmaceuticals Recent Development
11.8 Alvogen (CVC Capital Partners and Temasek )
11.8.1 Alvogen (CVC Capital Partners and Temasek ) Company Details
11.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview
11.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Introduction
11.8.4 Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2015-2020)
11.8.5 Alvogen (CVC Capital Partners and Temasek ) Recent Development
11.9 Acella Pharmaceuticals
11.9.1 Acella Pharmaceuticals Company Details
11.9.2 Acella Pharmaceuticals Business Overview
11.9.3 Acella Pharmaceuticals Ciclopirox Olamine Introduction
11.9.4 Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.9.5 Acella Pharmaceuticals Recent Development
11.10 Dr Marc's Manufacturing
11.10.1 Dr Marc's Manufacturing Company Details
11.10.2 Dr Marc's Manufacturing Business Overview
11.10.3 Dr Marc's Manufacturing Ciclopirox Olamine Introduction
11.10.4 Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2015-2020)
11.10.5 Dr Marc's Manufacturing Recent Development
11.11 Paddock Laboratories (Perrigo)
10.11.1 Paddock Laboratories (Perrigo) Company Details
10.11.2 Paddock Laboratories (Perrigo) Business Overview
10.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Introduction
10.11.4 Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2015-2020)
10.11.5 Paddock Laboratories (Perrigo) Recent Development
11.12 Sincerus
10.12.1 Sincerus Company Details
10.12.2 Sincerus Business Overview
10.12.3 Sincerus Ciclopirox Olamine Introduction
10.12.4 Sincerus Revenue in Ciclopirox Olamine Business (2015-2020)
10.12.5 Sincerus Recent Development
11.13 Glades Pharmaceuticals (GSK)
10.13.1 Glades Pharmaceuticals (GSK) Company Details
10.13.2 Glades Pharmaceuticals (GSK) Business Overview
10.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Introduction
10.13.4 Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2015-2020)
10.13.5 Glades Pharmaceuticals (GSK) Recent Development
11.14 Sterimax
10.14.1 Sterimax Company Details
10.14.2 Sterimax Business Overview
10.14.3 Sterimax Ciclopirox Olamine Introduction
10.14.4 Sterimax Revenue in Ciclopirox Olamine Business (2015-2020)
10.14.5 Sterimax Recent Development
11.15 Guangzhou Kanghe Pharmaceutical
10.15.1 Guangzhou Kanghe Pharmaceutical Company Details
10.15.2 Guangzhou Kanghe Pharmaceutical Business Overview
10.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Introduction
10.15.4 Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.15.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.16 Tianjin Lisheng Pharmaceutical
10.16.1 Tianjin Lisheng Pharmaceutical Company Details
10.16.2 Tianjin Lisheng Pharmaceutical Business Overview
10.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Introduction
10.16.4 Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.16.5 Tianjin Lisheng Pharmaceutical Recent Development
11.17 Zhejiang Xianju Pharmaceutical
10.17.1 Zhejiang Xianju Pharmaceutical Company Details
10.17.2 Zhejiang Xianju Pharmaceutical Business Overview
10.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Introduction
10.17.4 Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.17.5 Zhejiang Xianju Pharmaceutical Recent Development
11.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
10.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
10.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
10.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Introduction
10.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2015-2020)
10.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ciclopirox Olamine Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Cream Preparation
1.2.3 Temperture
1.2.4 Vaginal Suppository
1.3 Market by Application
1.3.1 Global Ciclopirox Olamine Market Share by Application: 2020 VS 2026
1.3.2 Ringworm Of The Body
1.3.3 Athlete'S Foot
1.3.4 Tinea
1.3.5 Tinea Versicolor
1.3.6 Candida Albicans
1.3.7 Gynecological Anti-Infection Preparation
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ciclopirox Olamine Market Perspective (2015-2026)
2.2 Global Ciclopirox Olamine Growth Trends by Regions
2.2.1 Ciclopirox Olamine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ciclopirox Olamine Historic Market Share by Regions (2015-2020)
2.2.3 Ciclopirox Olamine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ciclopirox Olamine Players by Market Size
3.1.1 Global Top Ciclopirox Olamine Players by Revenue (2015-2020)
3.1.2 Global Ciclopirox Olamine Revenue Market Share by Players (2015-2020)
3.2 Global Ciclopirox Olamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ciclopirox Olamine Revenue
3.4 Global Ciclopirox Olamine Market Concentration Ratio
3.4.1 Global Ciclopirox Olamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ciclopirox Olamine Revenue in 2019
3.5 Key Players Ciclopirox Olamine Area Served
3.6 Key Players Ciclopirox Olamine Product Solution and Service
3.7 Date of Enter into Ciclopirox Olamine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ciclopirox Olamine Breakdown Data by Type (2015-2026)
4.1 Global Ciclopirox Olamine Historic Market Size by Type (2015-2020)
4.2 Global Ciclopirox Olamine Forecasted Market Size by Type (2021-2026)
5 Ciclopirox Olamine Breakdown Data by Application (2015-2026)
5.1 Global Ciclopirox Olamine Historic Market Size by Application (2015-2020)
5.2 Global Ciclopirox Olamine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ciclopirox Olamine Market Size (2015-2026)
6.2 North America Ciclopirox Olamine Market Size by Type (2015-2020)
6.3 North America Ciclopirox Olamine Market Size by Application (2015-2020)
6.4 North America Ciclopirox Olamine Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Ciclopirox Olamine Market Size (2015-2026)
7.2 Europe Ciclopirox Olamine Market Size by Type (2015-2020)
7.3 Europe Ciclopirox Olamine Market Size by Application (2015-2020)
7.4 Europe Ciclopirox Olamine Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Ciclopirox Olamine Market Size (2015-2026)
8.2 China Ciclopirox Olamine Market Size by Type (2015-2020)
8.3 China Ciclopirox Olamine Market Size by Application (2015-2020)
8.4 China Ciclopirox Olamine Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Ciclopirox Olamine Market Size (2015-2026)
9.2 Japan Ciclopirox Olamine Market Size by Type (2015-2020)
9.3 Japan Ciclopirox Olamine Market Size by Application (2015-2020)
9.4 Japan Ciclopirox Olamine Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Ciclopirox Olamine Market Size (2015-2026)
10.2 Southeast Asia Ciclopirox Olamine Market Size by Type (2015-2020)
10.3 Southeast Asia Ciclopirox Olamine Market Size by Application (2015-2020)
10.4 Southeast Asia Ciclopirox Olamine Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ciclopirox Olamine Introduction
11.1.4 Bayer Revenue in Ciclopirox Olamine Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 Apotex Corporation
11.2.1 Apotex Corporation Company Details
11.2.2 Apotex Corporation Business Overview
11.2.3 Apotex Corporation Ciclopirox Olamine Introduction
11.2.4 Apotex Corporation Revenue in Ciclopirox Olamine Business (2015-2020)
11.2.5 Apotex Corporation Recent Development
11.3 Fougera (Sandoz)
11.3.1 Fougera (Sandoz) Company Details
11.3.2 Fougera (Sandoz) Business Overview
11.3.3 Fougera (Sandoz) Ciclopirox Olamine Introduction
11.3.4 Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2015-2020)
11.3.5 Fougera (Sandoz) Recent Development
11.4 Medimetriks Pharmaceuticals
11.4.1 Medimetriks Pharmaceuticals Company Details
11.4.2 Medimetriks Pharmaceuticals Business Overview
11.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Introduction
11.4.4 Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.4.5 Medimetriks Pharmaceuticals Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Details
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Ciclopirox Olamine Introduction
11.5.4 Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Preferred Pharmaceuticals
11.6.1 Preferred Pharmaceuticals Company Details
11.6.2 Preferred Pharmaceuticals Business Overview
11.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Introduction
11.6.4 Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.6.5 Preferred Pharmaceuticals Recent Development
11.7 Ingenus Pharmaceuticals
11.7.1 Ingenus Pharmaceuticals Company Details
11.7.2 Ingenus Pharmaceuticals Business Overview
11.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Introduction
11.7.4 Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.7.5 Ingenus Pharmaceuticals Recent Development
11.8 Alvogen (CVC Capital Partners and Temasek )
11.8.1 Alvogen (CVC Capital Partners and Temasek ) Company Details
11.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview
11.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Introduction
11.8.4 Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2015-2020)
11.8.5 Alvogen (CVC Capital Partners and Temasek ) Recent Development
11.9 Acella Pharmaceuticals
11.9.1 Acella Pharmaceuticals Company Details
11.9.2 Acella Pharmaceuticals Business Overview
11.9.3 Acella Pharmaceuticals Ciclopirox Olamine Introduction
11.9.4 Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2015-2020)
11.9.5 Acella Pharmaceuticals Recent Development
11.10 Dr Marc's Manufacturing
11.10.1 Dr Marc's Manufacturing Company Details
11.10.2 Dr Marc's Manufacturing Business Overview
11.10.3 Dr Marc's Manufacturing Ciclopirox Olamine Introduction
11.10.4 Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2015-2020)
11.10.5 Dr Marc's Manufacturing Recent Development
11.11 Paddock Laboratories (Perrigo)
10.11.1 Paddock Laboratories (Perrigo) Company Details
10.11.2 Paddock Laboratories (Perrigo) Business Overview
10.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Introduction
10.11.4 Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2015-2020)
10.11.5 Paddock Laboratories (Perrigo) Recent Development
11.12 Sincerus
10.12.1 Sincerus Company Details
10.12.2 Sincerus Business Overview
10.12.3 Sincerus Ciclopirox Olamine Introduction
10.12.4 Sincerus Revenue in Ciclopirox Olamine Business (2015-2020)
10.12.5 Sincerus Recent Development
11.13 Glades Pharmaceuticals (GSK)
10.13.1 Glades Pharmaceuticals (GSK) Company Details
10.13.2 Glades Pharmaceuticals (GSK) Business Overview
10.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Introduction
10.13.4 Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2015-2020)
10.13.5 Glades Pharmaceuticals (GSK) Recent Development
11.14 Sterimax
10.14.1 Sterimax Company Details
10.14.2 Sterimax Business Overview
10.14.3 Sterimax Ciclopirox Olamine Introduction
10.14.4 Sterimax Revenue in Ciclopirox Olamine Business (2015-2020)
10.14.5 Sterimax Recent Development
11.15 Guangzhou Kanghe Pharmaceutical
10.15.1 Guangzhou Kanghe Pharmaceutical Company Details
10.15.2 Guangzhou Kanghe Pharmaceutical Business Overview
10.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Introduction
10.15.4 Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.15.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.16 Tianjin Lisheng Pharmaceutical
10.16.1 Tianjin Lisheng Pharmaceutical Company Details
10.16.2 Tianjin Lisheng Pharmaceutical Business Overview
10.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Introduction
10.16.4 Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.16.5 Tianjin Lisheng Pharmaceutical Recent Development
11.17 Zhejiang Xianju Pharmaceutical
10.17.1 Zhejiang Xianju Pharmaceutical Company Details
10.17.2 Zhejiang Xianju Pharmaceutical Business Overview
10.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Introduction
10.17.4 Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2015-2020)
10.17.5 Zhejiang Xianju Pharmaceutical Recent Development
11.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
10.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
10.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
10.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Introduction
10.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2015-2020)
10.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
